Title : Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.

Pub. Date : 2007 Jan

PMID : 17190843






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Clinical studies to date indicate that DPP-4 inhibitors effectively stimulate insulin secretion, suppress glucagon release, and improve glucose control in patients with type 2 diabetes. Glucagon dipeptidyl peptidase 4 Homo sapiens